About Us | Contact

Kevin Wayne Byram Investigator

Rheumatology Vanderbilt University Medical Center NPI1841566056
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$1,114.87
from 10 payments in the last 6 years

Total Cash or Cash Equivalent

$0.00
from 0 payments in the last 6 years

Total In-kind Items & Services

$1,114.87
from 10 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
05/04/2018 General (Non-Research) In-kind items and services Food and Beverage $45.28 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 607922583
10/13/2018 Research In-kind items and services Drug $30.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602045441
10/12/2018 Research In-kind items and services Drug $94.48 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602007186
10/12/2018 Research In-kind items and services Drug $19.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602007181
10/12/2018 Research In-kind items and services Drug $50.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602007177
10/11/2018 Research In-kind items and services Drug $180.07 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602006949
10/11/2018 Research In-kind items and services Drug $301.55 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602006943
10/11/2018 Research In-kind items and services Drug $311.49 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602006937
10/13/2018 Research In-kind items and services Drug $50.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602004351
10/13/2018 Research In-kind items and services Drug $33.00 Details
Payment from SANOFI US SERVICES INC.
Paymment Research Study A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis
Clinical Trials Gov ID NCT03600805
Payment Record ID 602004343
;